Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial-Reference-Cited by-同舟云学术

Ultra-hypofractionated versus conventionally fractionated radiotherapy for prostate cancer (HYPO-RT-PC): patient-reported quality-of-life outcomes of a randomised, controlled, non-inferiority, phase 3 trial

Published:2021-02 Issue:2 Volume:22 Page:235-245
ISSN:1470-2045
Container-title:The Lancet Oncology
language:en
Short-container-title:The Lancet Oncology

Author:

Fransson Per,Nilsson Per,Gunnlaugsson Adalsteinn,Beckman Lars,Tavelin Björn,Norman David,Thellenberg-Karlsson Camilla,Hoyer Morten,Lagerlund Magnus,Kindblom Jon,Ginman Claes,Johansson Bengt,Björnlinger Kirsten,Seke Mihajl,Agrup Måns,Zackrisson Björn,Kjellén Elisabeth,Franzén Lars,Widmark Anders

Publisher

Elsevier BV

Subject

Oncology

Reference30 articles.

1. Ultrahypofractionation should be a standard of care option for intermediate-risk prostate cancer;Loblaw;Clin Oncol (R Coll Radiol),2020

2. Hypofractionated radiation therapy for localized prostate cancer: executive summary of an ASTRO, ASCO and AUA evidence-based guideline;Morgan;J Urol,2019

3. Quality of life and satisfaction with outcome among prostate-cancer survivors;Sanda;N Engl J Med,2008

4. Differing perceptions of quality of life in patients with prostate cancer and their doctors;Sonn;J Urol,2013

5. Patient-reported outcomes after monitoring, surgery, or radiotherapy for prostate cancer;Donovan;N Engl J Med,2016

Cited by 101 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Acute toxicity patterns and their management after moderate and ultra- hypofractionated radiotherapy for prostate cancer: A prospective cohort study;Clinical and Translational Radiation Oncology;2024-09

2. Facing the climate change: is radiotherapy as green as we would like? A systematic review;Critical Reviews in Oncology/Hematology;2024-09

3. Escalade de dose en radiothérapie modérément hypofractionnée pour les cancers de la prostate localisés, ESHYPRO : résultats d’une série monocentrique rétrospective évaluant la toxicité et l’efficacité;Cancer/Radiothérapie;2024-08

4. Image guided radiotherapy in curative treatment for prostate cancer. 5-year results from a randomized controlled trial (RIC-trial);Radiotherapy and Oncology;2024-07

5. Ablative Radiation Therapy for Unfavorable Prostate Tumors (ABRUPT): Preliminary Analysis of Toxicity and Quality of Life from a Prospective Study;International Journal of Radiation Oncology*Biology*Physics;2024-07